P-281 JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1 antibody) maintenance therapy vs continuation of first-line chemotherapy in patients with unresectable, locally adv...

von Julien, Taieb, Maria, Di Bartolomeo, Antonio, Cubillo, Jayne, Gurtler, Deborah, Wilbur, Huiling, Xiong, Jenny, Zhang, Jean-Marie, Cuillerot, Narikazu, Boku, Markus, Moehler
Veröffentlicht in Ann Oncol (2016)

P-282 JAVELIN Gastric 300: Phase 3 trial of avelumab (anti-PD-L1 antibody) + best supportive care (BSC) vs BSC ± chemotherapy as third-line treatment for advanced gastric or gastro...

von Eric, Van Cutsem, Lucjan, Wyrwicz, Keun-Wook, Lee, Fortunato, Ciardiello, Rosine, Guimbaud, Julien, Taieb, Jayne, Gurtler, Narikazu, Boku, Huiling, Xiong, Jenny, Zhang, Jean-Marie, Cuillerot, Yung-Jue, Bang
Veröffentlicht in Ann Oncol (2016)